Eros International PLC NYSE Listing & Cancellation of Admission to AIM (9545S)

TIDMEROS

RNS Number : 9545S

Eros International PLC

13 November 2013

Eros International Plc ("Eros" or the "Company")

13(th) November 2013

NYSE Listing and Cancellation of Admission to AIM

Eros confirms that the Company's NYSE listing has become effective today and the cancellation of the Company's admission to AIM is expected to take place at 7.00 a.m. tomorrow, 14(th) November 2013.

For further information, please contact:

Andrew Heffernan

Chief Financial Officer

Eros International Plc

Sean Hanafin

Chief Corporate & Strategy Officer

T: +44 (0)20 7258 9909

Jamie M.M. Kirkwood

VP, Investor Relations

T: +44 (0)20 7258 9906

Investec Bank plc

Nominated Adviser & Joint Broker

Jeremy Ellis / Carlton Nelson / Patrick Robb

T: +44 (0) 20 7597 5000

Peel Hunt LLP

Joint broker

Richard Kauffer / Dan Harris / Andy Crossley

T: +44 (0) 20 7418 8900

About Eros International Plc

-- Eros co-produces, acquires and distributes Indian language films, in multiple formats worldwide

   --      In 2006, Eros listed its shares on the AIM Market of the London Stock Exchange

-- In October 2010, Eros listed its Indian subsidiary Eros International Media on the BSE & NSE in India

-- Eros operates in over 50 countries, with offices throughout India, the United Kingdom, USA, UAE, Singapore, Australia, Fiji and the Isle of Man

A registration statement and post-effective amendment relating to the Company's A ordinary shares has been filed with and declared effective by the United States Securities and Exchange Commission. This document shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any offer or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

Some of the information presented in this press release and in related comments by the Company's management contains forward-looking statements. In some cases, these forward-looking statements are identified by terms and phrases such as "aim," "anticipate," "believe," "feel," "contemplate," "intend," "estimate," "expect," "continue," "should," "could," "may," "plan," "project," "predict," "will," "future, " "goal," "objective," and similar expressions and include references to assumptions and relate to the Company's future prospects, developments and business strategies. Similarly, statements that describe the Company's strategies, objectives, plans or goals and statements regarding the proposed offering and the anticipated costs of these transactions are forward-looking statements and are based on information available to the Company as of the date of this press release. Forward-looking statements are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those contemplated by the relevant statement. Such risks and uncertainties include a variety of factors, some of which are beyond the Company's control. In particular, such risks and uncertainties include market conditions. Information concerning these and other factors that could cause results to differ materially from those contained in the forward-looking statements is contained under the caption "Risk Factors" in the Company's Registration Statement on Form F-1 filed with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to revise the forward-looking statements included in herein to reflect any future events or circumstances, except as required by law. The Company's actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCEXLFFXFFBFBL

Eros (LSE:EROS)
Historical Stock Chart
From Nov 2024 to Dec 2024